Richard Condon, CEO Aspire Pharma, discusses successful leadership
Leading lights
Related Posts
BioMed X launches call for applications in autoimmune disease research
The project will explore the biology of human autoreactive plasma cells BioMed X has announced the launch of a new call for […]
Calluna Pharma announces €75m series A financing for immunological diseases
The new company will develop novel therapies to benefit the body’s immune system Oxitope Pharma and Arxx Therapeutics have announced their merger to form Calluna […]
Microbiotica begins human trials for ulcerative colitis treatment
First patient dosed in phase 1b trial of MB310 therapy Microbiotica, a clinical-stage biopharma company, has announced the dosing of the first patient in its […]